HPV Type 16 L1 Protein - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
CERVARIX human papillomavirus vaccine types 16 and 18 [recombinant, AS04 adjuvanted] suspension for injection pre-filled syringe AUST R: 126114Active ingredients:
HPV Type 16 L1 Protein
HPV Type 18 L1 Protein
Dosage form:
Injection, suspension
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
Deletion from market:
11 Nov 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Patients are advised to consult their health professional to discuss alternative treatment options.
|